Caricamento...
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
SIMPLE SUMMARY: The introduction of immune checkpoint inhibitors (ICI) in 2011 revolutionized the management of many solid cancers and hematological malignancies. However, there are concerns regarding the use of ICI in the era of COVID-19. We present currently available information on the pros and c...
Salvato in:
| Pubblicato in: | Cancers (Basel) |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7698088/ https://ncbi.nlm.nih.gov/pubmed/33207589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113383 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|